ARTICLE | Clinical News
DigiTAb polyclonal antibody regulatory update
October 18, 1999 7:00 AM UTC
The FDA accepted for filing PTI's PLA/ELA for its DigiTAb to treat digoxin (digitalis) toxicity. The acceptance triggered a $250,000 milestone payment from U.S. marketing partner Altana Inc. (Melvill...